Novo Nordisk’s New Wegovy Trial Could Mean Smaller Pills, Fewer Side Effects
Novo Nordisk just started a trial that could change how doctors prescribe. The question is simple. Can a smaller…
-
-
Meant Introduces Certified GLP-1 Virtual Care Platform and Lifestyle Support
Meant, a new weight-loss telehealth startup, is entering an already crowded market. To launch, the company secured LegitScript certification….
-
How Generic Semaglutide Could Make Heart and Kidney Care Far More Affordable
When generic versions of semaglutide hit the market, a massive financial roadblock will finally come down for millions of…
-
Can Semaglutide Help People Quit Smoking?
Smoking is still one of the leading causes of preventable death worldwide. Because of this, doctors are always looking…
-
GLP-1 Medications vs. Traditional Dieting: How They Actually Work
Obesity is a major health challenge, and doctors are constantly comparing medication options against standard lifestyle changes. New weight-loss…
-
GLP-1 Before Surgery: Anesthesia, Colonoscopy, and Sedation
Glucagon-like peptide-1 receptor agonists have transformed the clinical management of obesity and type 2 diabetes. Medications such as Ozempic,…
-
Shifting GLP-1 Research and Development: Lessons From the First Generation
Glucagon-like peptide-1 (GLP-1) drugs have completely changed how doctors manage obesity and type 2 diabetes over the last twenty…
-
Evaluating Semaglutide and Menstrual Function: A Clinical Overview
If you are taking Wegovy or thinking about starting it, you might wonder how it affects your body beyond…
-
Hormonal Contraceptives and Semaglutide Initiation
New research has found a link between using hormonal birth control and later starting semaglutide, the drug many people…
-
GLP-1 Patient Support Market Set to Hit $2.85 Billion by 2036, Driven by Onboarding Demand
The market for GLP-1 patient support services is growing fast. Fact.MR now pegs it at $545 million in 2026….
